93 related articles for article (PubMed ID: 9846183)
1. Rel blocks both anti-Fas- and TNF alpha-induced apoptosis and an intact Rel transactivation domain is essential for this effect.
Zong WX; Bash J; Gélinas C
Cell Death Differ; 1998 Nov; 5(11):963-72. PubMed ID: 9846183
[TBL] [Abstract][Full Text] [Related]
2. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
Chen X; Kandasamy K; Srivastava RK
Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
[TBL] [Abstract][Full Text] [Related]
3. v-Rel prevents apoptosis in transformed lymphoid cells and blocks TNFalpha-induced cell death.
Zong WX; Farrell M; Bash J; Gélinas C
Oncogene; 1997 Aug; 15(8):971-80. PubMed ID: 9285692
[TBL] [Abstract][Full Text] [Related]
4. The v-Rel oncoprotein increases expression from Sp1 site-containing promoters in chicken embryo fibroblasts.
Sif S; Capobianco AJ; Gilmore TD
Oncogene; 1993 Sep; 8(9):2501-9. PubMed ID: 8361761
[TBL] [Abstract][Full Text] [Related]
5. Two novel functions associated with the Rel oncoproteins: DNA replication and cell-specific transcriptional activation.
Ishikawa H; Asano M; Kanda T; Kumar S; Gélinas C; Ito Y
Oncogene; 1993 Nov; 8(11):2889-96. PubMed ID: 8414493
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor alpha prevents tumor necrosis factor receptor-mediated mouse hepatocyte apoptosis, but not fas-mediated apoptosis: role of nuclear factor-kappaB.
Nagaki M; Naiki T; Brenner DA; Osawa Y; Imose M; Hayashi H; Banno Y; Nakashima S; Moriwaki H
Hepatology; 2000 Dec; 32(6):1272-9. PubMed ID: 11093734
[TBL] [Abstract][Full Text] [Related]
7. Glabridin suppresses intercellular adhesion molecule-1 expression in tumor necrosis factor-alpha-stimulated human umbilical vein endothelial cells by blocking sphingosine kinase pathway: implications of Akt, extracellular signal-regulated kinase, and nuclear factor-kappaB/Rel signaling pathways.
Kang JS; Yoon YD; Han MH; Han SB; Lee K; Lee KH; Park SK; Kim HM
Mol Pharmacol; 2006 Mar; 69(3):941-9. PubMed ID: 16354764
[TBL] [Abstract][Full Text] [Related]
8. Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein.
Epinat JC; Kazandjian D; Harkness DD; Petros S; Dave J; White DW; Gilmore TD
Oncogene; 2000 Feb; 19(5):599-607. PubMed ID: 10698504
[TBL] [Abstract][Full Text] [Related]
9. TNF-alpha induces transient resistance to Fas-induced apoptosis in eosinophilic acute myeloid leukemia cells.
Qin Y; Auh S; Blokh L; Long C; Gagnon I; Hamann KJ
Cell Mol Immunol; 2007 Feb; 4(1):43-52. PubMed ID: 17349210
[TBL] [Abstract][Full Text] [Related]
10. Divergent C-terminal transactivation domains of Rel/NF-kappa B proteins are critical determinants of their oncogenic potential in lymphocytes.
Fan Y; Rayet B; Gélinas C
Oncogene; 2004 Feb; 23(5):1030-42. PubMed ID: 14647412
[TBL] [Abstract][Full Text] [Related]
11. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence.
Mosialos G; Gilmore TD
Oncogene; 1993 Mar; 8(3):721-30. PubMed ID: 8437855
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
Huerta-Yepez S; Vega M; Garban H; Bonavida B
Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
[TBL] [Abstract][Full Text] [Related]
13. Dual apoptotic effect of Xrel3 c-Rel/NF-kappaB homolog in human cervical cancer cells.
Shehata M; Shehata M; Shehata F; Pater A
Cell Biol Int; 2004; 28(12):895-904. PubMed ID: 15566959
[TBL] [Abstract][Full Text] [Related]
14. Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity.
Starczynowski DT; Trautmann H; Pott C; Harder L; Arnold N; Africa JA; Leeman JR; Siebert R; Gilmore TD
Oncogene; 2007 Apr; 26(19):2685-94. PubMed ID: 17072339
[TBL] [Abstract][Full Text] [Related]
15. Immortalized fibroblasts from NF-kappaB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor alpha after transformation by v-Ras.
Gapuzan ME; Schmah O; Pollock AD; Hoffmann A; Gilmore TD
Oncogene; 2005 Sep; 24(43):6574-83. PubMed ID: 16027734
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of Fas-mediated cell death and its enhancement by TNF-alpha in human salivary gland adenocarcinoma cell line HSG.
Chosa N; Kyakumoto S; Kito N; Kamo M; Sato N
Eur J Oral Sci; 2004 Aug; 112(4):338-46. PubMed ID: 15279653
[TBL] [Abstract][Full Text] [Related]
17. The c-Rel transcription factor can both induce and inhibit apoptosis in the same cells via the upregulation of MnSOD.
Bernard D; Monte D; Vandenbunder B; Abbadie C
Oncogene; 2002 Jun; 21(28):4392-402. PubMed ID: 12080470
[TBL] [Abstract][Full Text] [Related]
18. The v-Rel oncoprotein complexes with new Rel- and RelA-related proteins in transformed cells.
Xu X; Gélinas C
Virology; 1995 Mar; 207(2):362-8. PubMed ID: 7886940
[TBL] [Abstract][Full Text] [Related]
19. NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis.
Hatano E; Bennett BL; Manning AM; Qian T; Lemasters JJ; Brenner DA
Gastroenterology; 2001 Apr; 120(5):1251-62. PubMed ID: 11266388
[TBL] [Abstract][Full Text] [Related]
20. The viral and cellular Rel oncoproteins induce the differentiation of P19 embryonal carcinoma cells.
Inuzuka M; Ishikawa H; Kumar S; Gélinas C; Ito Y
Oncogene; 1994 Jan; 9(1):133-40. PubMed ID: 8302572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
